News

Novo Nordisk Reports Positive Results for Growth Disorder Treatment
Novo Nordisk reported positive data from a late-stage trial of its once-weekly Sogroya treatment for children with growth disorders.
Bangkok Post on MSN4d
Novo Nordisk, Nanyang Launch Shoes for Haemophilia Awareness
Ltd. (Novo Nordisk), a global healthcare company committed to driving change in chronic diseases, has announced the delivery of unique shoes, produced in collaboration with renowned Thai shoe ...
ScandAsia5d
Novo Nordisk and Nanyang raise haemophilia awareness in Thailand
In a unique collaboration to raise awareness of haemophilia in Thailand, Danish healthcare company Novo Nordisk and Thai ...
Novo Nordisk Latest Drugmaker to Drop Gender Goals in US
COPENHAGEN/LONDON (Reuters) - Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation ...
Novo Nordisk's CFO sceptical Trump executive order on drug manufacturing can cut timelines
Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...
DR6d
Isbjørne-tracker skal hjælpe forskere og holde øje med havisen
- Vi ved fra trackeren, at der er områder, hvor isbjørnene tidligere søgte hen for at få unger, som nu er utilgængelige.
Berlingske6d
Myanmars militærjunta forlænger våbenhvile efter jordskælv
Myanmars militærjunta forlænger en midlertidig våbenhvile i landet til den 31. maj. Det skriver statslige medier i landet ...